JOHN MICHAEL DUNN Insider Trading
Get free email notifications about insider trading for JOHN MICHAEL DUNN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN MICHAEL DUNN. JOHN MICHAEL DUNN is a EVP - New Ventures in BIOGEN INC. ($IDPH) and a in Acer Therapeutics Inc. ($OPXA) and a Director in Acer Therapeutics Inc. ($ACER) and a General Counsel and Secretary in VITAL THERAPIES INC ($VTL).
Address: 3030 CALLAN RD SAN DIEGO 92121 CA
Companies in which JOHN MICHAEL DUNN is an Insider
Acer Therapeutics Inc.
Trading Symbol: ACERIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN MICHAEL DUNN: Director
Holdings: 27,380 shares
Current Value: $27,928
Latest Transaction: Jan 20 2021
$ACER Market Capitalization: $7.21M
$ACER Previous Close: $1.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOGEN INC.
Trading Symbol: IDPHIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN MICHAEL DUNN: EVP - New Ventures
Holdings: 11,609 shares
Latest Transaction: Feb 10 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNIC, INC.
Trading Symbol: VTLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN MICHAEL DUNN: General Counsel and Secretary
Holdings: 9,485 shares
Current Value: $44,105
Latest Transaction: Jan 14 2019
$VTL Market Capitalization: $153.84M
$VTL Previous Close: $4.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN MICHAEL DUNN
Sentiment: All, ACER, IDPH, VTL
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 20 2021 | ACER | Acer Therapeutics ... | DUNN JOHN MICHAEL | Director | Option Exercise | A | 3.85 | 15,000 | 57,750 | 15,000 | |
Jul 28 2020 | ACER | Acer Therapeutics ... | DUNN JOHN MICHAEL | Director | Buy | P | 3.50 | 21,428 | 74,998 | 27,380 | 6 K to 27.4 K (+360.01 %) |
Feb 05 2019 | ACER | Acer Therapeutics ... | DUNN JOHN MICHAEL | Director | Option Exercise | A | 24.46 | 6,000 | 146,760 | 6,000 | |
Feb 05 2019 | ACER | Acer Therapeutics ... | DUNN JOHN MICHAEL | Director | Option Exercise | A | 24.46 | 6,000 | 146,760 | 6,000 | |
Jan 14 2019 | VTL | VITAL THERAPIES IN ... | DUNN JOHN MICHAEL | General Counsel and ... | Option Exercise | A | 0.00 | 724,848 | 0 | 724,848 | |
Jan 14 2019 | VTL | VITAL THERAPIES IN ... | DUNN JOHN MICHAEL | General Counsel and ... | Option Exercise | A | 0.00 | 724,848 | 0 | 724,848 | |
Jan 14 2019 | VTL | VITAL THERAPIES IN ... | DUNN JOHN MICHAEL | General Counsel and ... | Option Exercise | D | 5.00 | 45,000 | 225,000 | 0 |